Lead locations. A, Lateral Xray of the implanted RNS System. B

Neuropace Pdms. NeuroPace RNS System for Epilepsy Gets FDA Approval for MRI Labeling are then transferred from the handheld device to the NeuroPace Patient Data Management System (PDMS) The secure web accessed PDMS interface is used by physicians to view the history of all neurostimulator programmings, all detections and stimulations, and sampled ECoGs

Customer Support: 1-866-726-3876 (Toll Free in the United States) Website: www.NeuroPace.com The first closed-loop device, the NeuroPace RNS System, was approved by the FDA for drug-resistant epilepsy in 2013 and demonstrated a median reduction in seizure frequency of 53% at two years and 72% at six years [6, 7].

NeuroPace on LinkedIn Using Brain Data & Neurotech to Treat Disease

The first closed-loop device, the NeuroPace RNS System, was approved by the FDA for drug-resistant epilepsy in 2013 and demonstrated a median reduction in seizure frequency of 53% at two years and 72% at six years [6, 7]. PHI CAUTION - The patient data accessible to you via the NeuroPace nSight Platform may constitute "protected health information" under HIPAA or "personal health information" under state law the NeuroPace Patient Data Management System (PDMS) using a Physician Programmer or Patient Remote Monitor

NeuroPace implants first patients with RNS System in NAUTILUS study. The first closed-loop device, the NeuroPace RNS System, was approved by the FDA for drug-resistant epilepsy in 2013 and demonstrated a median reduction in seizure frequency of 53% at two years and 72% at six years [6, 7]. NeuroPace technical experts; Interactive Activity Trend Chart

NIH Study to Utilize NeuroPace RNS System for Research on the Brain’s. Customer Support: 1-866-726-3876 (Toll Free in the United States) Website: www.NeuroPace.com NeuroPace may review the information and any photographs you provide for potential publication on our website